Alyssa Farquhar Appointed as EVP, Managing Director, Creative at BGB Group

New York, United States, December 2025 – Alyssa Farquhar has been appointed as EVP, Managing Director, Creative at BGB Group, where she will lead the agency’s creative vision, brand storytelling strategy, and integrated healthcare communications across BGB’s global portfolio of clients.

Kaylee Darkins Appointed as Chief People and Communications Officer at OAK Global

Rebecca Young Appointed as Chief Human Resources Officer at Advita Ortho

Nina Aguilar Appointed as Chief Human Resources Officer at FIA Tech

At BGB Group, Alyssa Farquhar brings forward her most recent elevation from EVP, Executive Creative Director to EVP, Managing Director, Creative, reflecting her growing leadership charter in shaping agency-wide creative direction, culture, and high-impact healthcare brand narratives.

Before her current role, she served at Area 23 as EVP, Executive Creative Director, where she led breakthrough creative campaigns across major healthcare brands, strengthening market engagement, strategic storytelling, and creative innovation.

Earlier, she spent several years at DDB Health New York, serving as EVP, Creative and Strategic Director, driving integrated marketing transformation, award-winning healthcare campaigns, and global brand strategies across key pharmaceutical portfolios.

Prior to this, Alyssa held senior leadership roles at Centron, The CDM Group, NeON Advertising, and Cline Davis & Mann, where she progressively built her reputation as a leading creative strategist and healthcare communications leader over more than two decades.

About BGB Group

BGB Group is a leading independent healthcare communications agency with approximately 500 employees and offices across the United States and the United Kingdom. Founded on the principle of integrating science and creativity, BGB delivers data-driven strategy, creative excellence, and agile execution across healthcare advertising, medical communications, strategic consulting, and market access. The agency leverages medical science, behavioral science, and data science to build compelling scientific stories that drive belief, behavior change, and brand growth.